Proposed Mechanism BPC-157 appears to work through multiple pathways: Maintaining vesicular integrity (affecting VMATs and dopamine transporters) Possibly occupying its own vesicular storage sites Competing for dopamine receptor binding Functionally substituting when dopaminergic neurons are lost This last property, essentially filling in for missing dopamine function, would explain why the peptide counteracts both receptor agonists (apomorphine) and antagonists (haloperidol, fluphenazine, clozapine, sulpiride) with equal effectiveness
UTIs, presumably due to reduced immune cell function
Ideal for anyone seeking gut, muscle, and joint support
Whether you are approaching AOD-9604 for the first time or refining an existing protocol, the information here comes from clinical research, established protocols, and practical application
Comfort and Care: Your comfort and well-being are our top priorities